Education
About Us
Working with TipRanks
Follow Us
Pro Medicus Limited (PMCUF)
OTHER OTC:PMCUF
PMCUF Stock Chart & Stats
$144.07
$0.00(0.00%)
At close: 4:00 PM EST
$144.07
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$100.45 - $218.25
Previous CloseN/A
Volume5.00
Average Volume (3M)176.00
Market Cap
$15.83B
Enterprise Value$29.63B
Total Cash (Recent Filing)$209.19M
Total Debt (Recent Filing)$2.25M
Price to Earnings (P/E)201.7
Beta1.50
Next Earnings
Feb 17, 2026EPS Estimate
0.45Next Dividend Ex-DateN/A
Dividend Yield0.26%
Share Statistics
EPS (TTM)0.40
Shares Outstanding104,510,840
10 Day Avg. Volume286
30 Day Avg. Volume176
Financial Highlights & Ratios
PEG Ratio6.59
Price to Book (P/B)115.91
Price to Sales (P/S)139.89
P/FCF Ratio286.51
Enterprise Value/Market Cap1.87
Enterprise Value/Revenue139.12
Enterprise Value/Gross Profit175.16
Enterprise Value/Ebitda173.66
Forecast
1Y Price Target
$222.81Price Target Upside54.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market AcceptanceOver 55% of surveyed US hospital executives are likely to deploy Pro Medicus's Visage 7 software, highlighting strong market acceptance and growth potential.
Product PerformanceThe Visage 7 software from Pro Medicus creates significant value for customers, making it 60-70% faster than legacy solutions and boosting customer volumes significantly.
Bears Say
Market SharePME's share of the US market remains low at 7%, which highlights the opportunity ahead, notwithstanding upside prospects from the core TAM, adjacencies and potential new markets.
Pro Medicus Limited News
PMCUF FAQ
What was Pro Medicus Limited’s price range in the past 12 months?
Pro Medicus Limited lowest stock price was $100.45 and its highest was $218.25 in the past 12 months.
What is Pro Medicus Limited’s market cap?
Pro Medicus Limited’s market cap is $15.83B.
When is Pro Medicus Limited’s upcoming earnings report date?
Pro Medicus Limited’s upcoming earnings report date is Feb 17, 2026 which is in 53 days.
How were Pro Medicus Limited’s earnings last quarter?
Pro Medicus Limited released its earnings results on Aug 13, 2025. The company reported $0.404 earnings per share for the quarter, beating the consensus estimate of $0.388 by $0.017.
Is Pro Medicus Limited overvalued?
According to Wall Street analysts Pro Medicus Limited’s price is currently Undervalued.
Does Pro Medicus Limited pay dividends?
Pro Medicus Limited pays a Semiannually dividend of $0.195 which represents an annual dividend yield of 0.26%. See more information on Pro Medicus Limited dividends here
What is Pro Medicus Limited’s EPS estimate?
Pro Medicus Limited’s EPS estimate is 0.45.
How many shares outstanding does Pro Medicus Limited have?
Pro Medicus Limited has 104,510,840 shares outstanding.
What happened to Pro Medicus Limited’s price movement after its last earnings report?
Pro Medicus Limited reported an EPS of $0.404 in its last earnings report, beating expectations of $0.388. Following the earnings report the stock price went up 3.519%.
Which hedge fund is a major shareholder of Pro Medicus Limited?
Currently, no hedge funds are holding shares in PMCUF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pro Medicus Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$222.81 (54.65% Upside)
$222.81 (54.65% Upside)
Blogger Sentiment
Bullish
PMCUF Sentiment 80%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.64%
12-Months-Change
Fundamentals
Return on Equity
50.70%
Trailing 12-Months
Asset Growth
29.11%
Trailing 12-Months
Company Description
Pro Medicus Limited
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
PMCUF Company Deck
PMCUF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with record revenue and profit growth, significant contract wins, and advancements in cloud and AI technology. However, challenges remain in expanding market penetration outside North America and navigating a competitive landscape.View all PMCUF earnings summariesPMCUF Stock 12 Month Forecast
Average Price Target
$222.81
▲(54.65% Upside)
Technical Analysis
Mach7 Technologies
―
Resonance Health Ltd
―
MedAdvisor Limited
―
Alcidion Group Limited
―
PainChek Ltd
―
Ownership Overview
46.26% Insiders
4.50% Mutual Funds
0.08% Other Institutional Investors
43.83% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---